Evidence map›Paper›PMID 39165432›Full record

ArticleCureus2024

Enhancing Chemotherapy Efficacy: Investigating the Synergistic Impact of Paclitaxel and cd73 Gene Suppression on Breast Cancer Cell Proliferation and Migration.

Farzaneh Hamidnia, Elif S Aslan, Souzan Najafi, Elham Baghbani, Sajjad Eslamkhah, Behzad Baradaran

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Farzaneh HamidniaMolecular Biology and Genetics, Biruni University, Istanbul, TUR.
Elif S AslanMolecular Biology and Genetics, Biruni University, Istanbul, TUR.
Souzan NajafiMedical Sciences, Immunology Research Center, Tabriz University, Tabriz, IRN.
Elham BaghbaniMedical Sciences, Immunology Research Center, Tabriz University, Tabriz, IRN.
Sajjad EslamkhahMolecular Biology and Genetics, Biruni University, Istanbul, TUR.
Behzad BaradaranMedical Sciences, Immunology Research Center, Tabriz University, Tabriz, IRN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Enhancing chemotherapy efficacy is crucial in breast cancer treatment. This study examines the synergistic effects of paclitaxel, a common chemotherapeutic drug, and Cluster of differentiation 73 (

Indexed as

apoptosisbreast cancercd73 sirnacell migrationcell viabilitychemotherapymda-mb-231paclitaxel

Identifiers

PMID39165432
PMCPMC11334381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.